|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.695
|
|
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.695
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.587
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.515
|
|
|
|
regulation of growth of symbiont in host
|
GO:0044126 |
19 |
0.506
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.475
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.380
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.353
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.342
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.332
|
|
|
|
growth of symbiont in host
|
GO:0044117 |
23 |
0.330
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.319
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.313
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.308
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.307
|
|
|
|
killing of cells in other organism involved in symbiotic interaction
|
GO:0051883 |
13 |
0.300
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.295
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.290
|
|
|
|
disruption by host of symbiont cells
|
GO:0051852 |
11 |
0.278
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.274
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.260
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.242
|
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
19 |
0.240
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.237
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.226
|
|
|
|
negative regulation of growth of symbiont involved in interaction with host
|
GO:0044146 |
19 |
0.226
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.225
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.216
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.210
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.206
|
|
|
|
leukocyte migration involved in inflammatory response
|
GO:0002523 |
7 |
0.206
|
|
|
|
growth of symbiont involved in interaction with host
|
GO:0044116 |
23 |
0.203
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.197
|
|
|
|
neutrophil mediated immunity
|
GO:0002446 |
19 |
0.193
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.189
|
|
|
|
killing by host of symbiont cells
|
GO:0051873 |
11 |
0.188
|
|
|
|
disruption of cells of other organism
|
GO:0044364 |
13 |
0.187
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.186
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.172
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.168
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.167
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.161
|
|
|
|
negative regulation of growth of symbiont in host
|
GO:0044130 |
19 |
0.158
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.156
|
|
|
|
leukocyte aggregation
|
GO:0070486 |
1 |
0.156
|
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.148
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.143
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.142
|
|
|
|
growth involved in symbiotic interaction
|
GO:0044110 |
23 |
0.139
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.139
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.124
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.122
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.121
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.119
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.118
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.118
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.117
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.116
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.116
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.116
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.112
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.112
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.109
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.108
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.104
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.103
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.103
|
|
|
|
protein citrullination
|
GO:0018101 |
2 |
0.101
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.101
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.101
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.100
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.100
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.099
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.098
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.098
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.097
|
|
|
|
response to zinc ion
|
GO:0010043 |
5 |
0.096
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.096
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.095
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.094
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.093
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.092
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.089
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.089
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.089
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.089
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.087
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.087
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.085
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.085
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.085
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.084
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.083
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.082
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.082
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.081
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.081
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.080
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.080
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.079
|
|
|
|
leukocyte cell cell adhesion
|
GO:0007159 |
14 |
0.079
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.079
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.077
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.077
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.076
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.075
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.075
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.075
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.075
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.074
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.073
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.072
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.072
|
|
|
|
killing of cells of other organism
|
GO:0031640 |
13 |
0.072
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.071
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.069
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.068
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.068
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.067
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.067
|
|
|
|
neutrophil mediated killing of fungus
|
GO:0070947 |
3 |
0.067
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.067
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.067
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.066
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.065
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.065
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.064
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.063
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.063
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.063
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.062
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.062
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.061
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.061
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.061
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.061
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.061
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.060
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.060
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.060
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.059
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.059
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.058
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.058
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.057
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.057
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.056
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.056
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.056
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.055
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.055
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.055
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.054
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.054
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.054
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.053
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.053
|
|
|
|
defense response to nematode
|
GO:0002215 |
4 |
0.052
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.052
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.051
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.051
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.050
|
|
|
|
amino sugar catabolic process
|
GO:0046348 |
1 |
0.050
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.050
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.050
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.050
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.049
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.049
|
|
|
|
alpha amino acid biosynthetic process
|
GO:1901607 |
15 |
0.049
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.049
|
|
|
|
respiratory burst
|
GO:0045730 |
8 |
0.049
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.049
|
|
|
|
cellular modified amino acid biosynthetic process
|
GO:0042398 |
12 |
0.049
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.048
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.048
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.048
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.048
|
|
|
|
lipoxin a4 biosynthetic process
|
GO:2001303 |
1 |
0.047
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.047
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.047
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.047
|
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.047
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.046
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.046
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.045
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
27 |
0.045
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.045
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.045
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.045
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.045
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.044
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.044
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.044
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.044
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.044
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.043
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.043
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.042
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.042
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.042
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.042
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.042
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.042
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.042
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.041
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.041
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.041
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.041
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.040
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.040
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.040
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.040
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.040
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.040
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.039
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.039
|
|
|
|
negative regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031665 |
3 |
0.039
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.039
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.039
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.039
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.039
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.039
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.039
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.039
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.038
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.038
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.038
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.038
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.038
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.038
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.038
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.038
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.038
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.038
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.038
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.037
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.037
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.037
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.037
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.037
|
|
|
|
antibacterial humoral response
|
GO:0019731 |
8 |
0.037
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.037
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.037
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.037
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.037
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.036
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.036
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.036
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.036
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.036
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.036
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.036
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.036
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.036
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.036
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.036
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.035
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.035
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.035
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.035
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.035
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.035
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.035
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.034
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.034
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.034
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.034
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.034
|
|
|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.034
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.034
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.034
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.034
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.034
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.033
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.033
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.033
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.033
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.033
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.033
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.033
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.033
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.033
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.033
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.033
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.033
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.032
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.032
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.032
|
|
|
|
neutrophil mediated cytotoxicity
|
GO:0070942 |
8 |
0.032
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.032
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.032
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.032
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.032
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.031
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.031
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.031
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.030
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.030
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.030
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.030
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.030
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.029
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.029
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.029
|
|
|
|
positive regulation of toll like receptor 4 signaling pathway
|
GO:0034145 |
1 |
0.029
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.029
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.029
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.029
|
|
|
|
negative regulation of interleukin 8 production
|
GO:0032717 |
1 |
0.029
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.028
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.028
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.028
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.028
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.028
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.028
|
|
|
|
regulation of integrin biosynthetic process
|
GO:0045113 |
1 |
0.028
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.028
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.028
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.028
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.028
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.027
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.027
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.027
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.027
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.027
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.027
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.027
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.027
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.027
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.027
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.026
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.026
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.026
|
|
|
|
modification by host of symbiont morphology or physiology
|
GO:0051851 |
12 |
0.026
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.026
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.026
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.026
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.026
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.026
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.026
|
|
|
|
integrin biosynthetic process
|
GO:0045112 |
1 |
0.026
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.026
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.026
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.025
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.025
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.025
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.025
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.025
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.025
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.025
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.025
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.025
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.025
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.025
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.025
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.025
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.025
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.025
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.025
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.025
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.025
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.025
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.025
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.025
|
|
|
|
mucosal immune response
|
GO:0002385 |
13 |
0.025
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.025
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.025
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.024
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.024
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.024
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.024
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.024
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.024
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.024
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.024
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.024
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.024
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.024
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.024
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.024
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.024
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.024
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.024
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.024
|
|
|
|
defense response to fungus
|
GO:0050832 |
12 |
0.024
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.024
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.024
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.024
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.024
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.024
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.024
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.024
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.023
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.023
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.023
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.023
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.023
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.023
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.023
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.023
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.023
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.023
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.023
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.023
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.023
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.023
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.023
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.022
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
27 |
0.022
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.022
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.022
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.022
|
|
|
|
phosphatidylethanolamine biosynthetic process
|
GO:0006646 |
2 |
0.022
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.022
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.022
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.022
|
|
|
|
citrulline metabolic process
|
GO:0000052 |
3 |
0.022
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.022
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.022
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.022
|
|
|
|
axonal fasciculation
|
GO:0007413 |
15 |
0.022
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.022
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.021
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.021
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.021
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.021
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.021
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.021
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.021
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.021
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.021
|
|
|
|
memory
|
GO:0007613 |
58 |
0.021
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.021
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.021
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.021
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.021
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.021
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.021
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.021
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.021
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.021
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.021
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.020
|
|
|
|
regulation of homotypic cell cell adhesion
|
GO:0034110 |
13 |
0.020
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.020
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.020
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.020
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.020
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.020
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.020
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.020
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.020
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.020
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.020
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.020
|
|
|
|
neutrophil mediated killing of symbiont cell
|
GO:0070943 |
8 |
0.020
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.020
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.020
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.020
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.020
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.020
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.020
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.020
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.020
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.019
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.019
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.019
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.019
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.019
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.019
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.019
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.019
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.019
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.019
|
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.019
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.019
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.019
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.019
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.019
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.019
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.019
|
|
|
|
positive regulation of ras protein signal transduction
|
GO:0046579 |
13 |
0.019
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.019
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.019
|
|